Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kosowska–Shick K et al. – No cross–resistance was found with any clone/antimicrobial combination. The two enterococci developed resistance to daptomycin, and one developed resistance to linezolid. Single–step mutation frequencies for telavancin were lower than the spontaneous mutation frequencies obtained with the comparators.

Related Articles

Telavancin for injection (Vibativ): Lipoglycopeptide antibiotic approved for the treatment of complicated skin and skin-structure infections
Formulary, 11/02/09    Relevance Score: 87%

Telavancin: A Novel Lipoglycopeptide
Clinical Infectious Diseases, 11/16/09    Relevance Score: 83%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address